Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the opening of a new branch in Dubai, UAE. This will house Sales staff focused upon developing Atnahs’ business throughout the Middle East and North Africa.
Dipen Patel, the General Manager of the new branch, comments,
“This is the next step in Atnahs’ strategy of establishing roots and branches in all of the regions in which it markets and distributes its medicines. This is a very exciting opportunity for us to invest in Dubai, the UAE and the region more widely, and to grow our business.”
Atnahs is a family-owned specialty pharmaceutical business, focused upon acquiring mature branded medicines globally, developing line extensions to them, and developing its own niche generic medicines. Atnahs has now completed eight major acquisitions since its inception in 2013, and operates a portfolio of over 17 key medicines across more than 130 markets.
Atnahs is based in Basildon, Copenhagen, Vadodara and Sydney.
Contact: Amit Patel at firstname.lastname@example.org or +44(0)1268 594777